Medical Instruments & Supplies · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Bionano Genomics, Inc. publishes a filing, an earnings call transcript or a press release.
Get BNGO alertsChris Stewart is recorded as CFO at Bionano Genomics, Inc. (BNGO). Chris Stewart has spoken on 5 earnings calls across 1 company, most recently for Bionano Genomics, Inc. on August 9, 2023. Bionano Genomics, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Bionano Genomics, Inc. includes Albert A. Luderer, Ph.D. (CEO and CFO), R. Erik Holmlin (CEO and Board Member), Albert Luderer (Chairman) and 7 others.
“Diving a little deeper into the numbers. Revenue in the second quarter of 2023 was $8.7 million reflecting an increase of $2 million or 30% over the second quarter of 2022 and exceeding our prior guidance of $7.8 million to $8.3 million for the quarter due mainly to increased demand for OGM instruments and consumables.”
“We got off to a strong start in 2023 with year-over-year revenue growth, and we continued the steady expansion of our installed base of Saphyr Systems.”
“The fourth quarter of 2022 was another outstanding quarter, which capped off a great year where we achieved impressive year-over-year revenue growth and diversified our revenue across product lines and geography.”
“The first quarter of 2022 is another great quarter for Bionano. We demonstrated strong performance in the face of our typical Q1 seasonal softness and the macro headwinds that Erik mentioned.”
“Let me start with a review of our financial results for the fourth quarter and year ended December 31, 2020. Revenue in Q4 was approximately $4 million consistent with the preliminary results that we issued back on January 7.”
Medical Instruments & Supplies · Healthcare
CFO